Lexicon Pharmaceuticals | LXRX - 营业费用



金融业
股票价格
USD
资产
USD 184.99M
现金及等价物
USD 21.36M
销售成本
USD 201K
流动资产
USD 101.9M
流动负债
USD 20.87M
债务
USD 99.51M
股息收益率
0
EBIT
USD -14.78M
EBITDA
USD -12.04M
员工
285
EPS每股收益
USD -0.04
股本和储备
USD 107.54M
销售毛利
USD 5.29M
债务利息支出
USD 2.03M
贷款资金
USD 49.41M
市值
USD 430.9M
净收入
USD -15.53M
营业费用
USD 20.27M
营业利润
USD -14.78M
普通股股本
USD 363.47M
PE价格收益
12.44
税前利润
USD -12.77M
销售收入
USD 5.49M
销售和管理费用
USD 3.99M
股票
USD 168K
贸易债权人
USD 3.08M
应收帐款人
USD 2.38M


营业费用 更改 日
Abbott USD 9.21B 17M 2025-12
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Coherus Biosciences USD 51.83M 2.48M 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Illumina USD 903M 69M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 17.44B 1.53B 2026-03
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
MacroGenics USD 53.32M 13.68M 2025-12
MannKind USD 119.64M 56.29M 2025-12
Merck USD 10.16B 558M 2025-12
Moderna USD 1.54B 259M 2025-12
Novartis USD 9.8B 61M 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Puma Biotechnology USD 49.26M 3.2M 2024-06
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
United Therapeutics USD 804.8M 5.79B 2025-12
Vanda Pharmaceuticals USD 466M 20.33M 2025-09